Waters Corp completes merger with BD's Biosciences business
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 09 2026
0mins
Should l Buy WAT?
Source: PRnewswire
Waters Corporation's stock fell 13.71% as it crossed below the 5-day SMA amid broader market declines, with the Nasdaq-100 down 0.34% and the S&P 500 down 0.17%.
The company has successfully completed its merger with Becton, Dickinson and Company's Biosciences and Diagnostic Solutions businesses, establishing a global leader in life sciences and diagnostics. This merger is expected to drive expansion in high-growth markets, with Dr. Claire M. Fraser appointed to the Waters Board to support future growth. The merger also resulted in the establishment of four new divisions focused on high-volume testing and adjacent markets, enhancing Waters' competitiveness.
The implications of this merger are significant, as it positions Waters Corporation to leverage its new capabilities and market presence. The company aims to capitalize on growth opportunities in pharmaceuticals and diagnostics, which could lead to increased revenue and market share in the coming years.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WAT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WAT
Wall Street analysts forecast WAT stock price to rise
13 Analyst Rating
8 Buy
5 Hold
0 Sell
Moderate Buy
Current: 293.370
Low
350.00
Averages
414.08
High
480.00
Current: 293.370
Low
350.00
Averages
414.08
High
480.00
About WAT
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Waters Corp. Prices $3.5B Senior Notes Offering
- Bond Offering Size: Waters Corp. has priced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo, which includes $650 million of 4.321% notes due 2027, $600 million of 4.398% notes due 2029, $750 million of 4.656% notes due 2031, $750 million of 4.945% notes due 2033, and $750 million of 5.245% notes due 2036, all issued at 100% of their principal amount.
- Clear Use of Proceeds: The net proceeds from this bond offering will be used alongside existing cash to repay $3.5 billion of indebtedness incurred by Augusta under a delayed draw term loan in February 2026, aiming to optimize the company's capital structure and reduce financial costs.
- Issuance Timeline: The bond offering is expected to close on or about March 23, 2026, providing the company with necessary liquidity to support its future financial plans.
- Future Financial Outlook: Waters projects revenue between $6.4 billion and $6.46 billion for 2026, targeting a margin of 28.1%, indicating the company's strategic goals in integrating BD, despite recent earnings reports falling short of market expectations.
See More
Waters Corp. Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corp. successfully priced a $3.5 billion multi-tranche senior notes offering through its subsidiary Augusta SpinCo Corp., featuring five tranches maturing between 2027 and 2036, with coupon rates ranging from 4.321% to 5.245%, all issued at par, indicating strong market acceptance of its debt instruments.
- Debt Repayment Strategy: The net proceeds from this offering will be used alongside cash on hand to repay a $3.5 billion delayed draw term loan incurred in February, aimed at optimizing the capital structure and reducing financial costs, thereby enhancing the company's financial flexibility.
- Market Reaction: In pre-market trading on the New York Stock Exchange, Waters Corp.'s stock rose by 0.15% to $297.41, reflecting investor confidence in the company's debt management and future financial health.
- Closing Timeline: The offering is expected to close on March 23, marking a proactive financing strategy in the capital markets that further supports the company's long-term growth objectives.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, expected to close on March 23, 2026, demonstrating the company's robust financing capability in the capital markets.
- Debt Repayment Strategy: The net proceeds from this offering will be used to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, aimed at optimizing the company's capital structure and reducing financial costs.
- Underwriter Lineup: Barclays Capital Inc. serves as the global coordinator, while Citigroup, J.P. Morgan, BofA Securities, and HSBC act as active bookrunners, indicating strong market interest and confidence in the offering.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities law, ensuring investors receive necessary investment information, thereby enhancing the company's credibility and transparency in the capital markets.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, which includes $650 million of 4.321% notes, $600 million of 4.398% notes, $750 million of 4.656% notes, $750 million of 4.945% notes, and $750 million of 5.245% notes, all issued at 100% of their principal amount, reflecting strong confidence in the capital markets.
- Use of Proceeds: The net proceeds from this offering will be used alongside cash on hand to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, significantly improving the company's financial structure and reducing debt burden, thereby enhancing future financial flexibility.
- Underwriter Lineup: The offering is being coordinated globally by Barclays Capital Inc., with Citigroup, J.P. Morgan, BofA Securities, and HSBC participating as active bookrunners, indicating strong market recognition and support for the transaction.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities laws, ensuring transparency and compliance, which further boosts investor confidence and lays a solid foundation for the company's future financing activities.
See More
Insider Buying by Waters and Arvinas Directors
- Waters Insider Purchase: Waters' Director Richard H. Fearon bought 1,000 shares at $306.34 each for a total of $306,340, marking his first purchase in the past year, indicating confidence in the company's future.
- Market Opportunity: Waters shares traded as low as $295.02 on Wednesday, 3.7% below Fearon's purchase price, presenting a relatively low entry point for investors, despite the stock being down about 1.2% on the day.
- Arvinas Insider Purchase: Arvinas' Director Briggs Morrison purchased 20,000 shares at $13.40 each for a total investment of $268,070, reflecting his positive outlook on the company's prospects.
- Historical Purchase Comparison: Prior to this purchase, Morrison had bought 227,010 shares at $7.57 each in the past year, demonstrating his sustained confidence in Arvinas, even as the stock fell approximately 3.2% on Wednesday.
See More
Waters CEO to Participate in Healthcare Conference
- Conference Participation: Waters Corporation's CEO, Dr. Udit Batra, will participate in the TD Cowen Healthcare Conference on March 2, 2026, at 11:10 AM ET, highlighting the company's leadership in life sciences.
- Live Webcast: The event will be streamed live on the 'Events & Presentations' section of Waters' Investor Relations website, ensuring global investors can access real-time updates and enhancing corporate transparency.
- Replay Availability: A replay of the webcast will be available for 90 days post-event, allowing investors who missed the live session to catch up, thereby improving information accessibility and engagement.
- Company Background: Waters Corporation focuses on life sciences and diagnostics, dedicated to accelerating scientific innovation through analytical technologies and informatics, driving the release of high-quality medicines and early disease detection, showcasing its global market influence.
See More
Waters Corp. Prices $3.5B Senior Notes Offering
- Bond Offering Size: Waters Corp. has priced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo, which includes $650 million of 4.321% notes due 2027, $600 million of 4.398% notes due 2029, $750 million of 4.656% notes due 2031, $750 million of 4.945% notes due 2033, and $750 million of 5.245% notes due 2036, all issued at 100% of their principal amount.
- Clear Use of Proceeds: The net proceeds from this bond offering will be used alongside existing cash to repay $3.5 billion of indebtedness incurred by Augusta under a delayed draw term loan in February 2026, aiming to optimize the company's capital structure and reduce financial costs.
- Issuance Timeline: The bond offering is expected to close on or about March 23, 2026, providing the company with necessary liquidity to support its future financial plans.
- Future Financial Outlook: Waters projects revenue between $6.4 billion and $6.46 billion for 2026, targeting a margin of 28.1%, indicating the company's strategic goals in integrating BD, despite recent earnings reports falling short of market expectations.
See More
Waters Corp. Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corp. successfully priced a $3.5 billion multi-tranche senior notes offering through its subsidiary Augusta SpinCo Corp., featuring five tranches maturing between 2027 and 2036, with coupon rates ranging from 4.321% to 5.245%, all issued at par, indicating strong market acceptance of its debt instruments.
- Debt Repayment Strategy: The net proceeds from this offering will be used alongside cash on hand to repay a $3.5 billion delayed draw term loan incurred in February, aimed at optimizing the capital structure and reducing financial costs, thereby enhancing the company's financial flexibility.
- Market Reaction: In pre-market trading on the New York Stock Exchange, Waters Corp.'s stock rose by 0.15% to $297.41, reflecting investor confidence in the company's debt management and future financial health.
- Closing Timeline: The offering is expected to close on March 23, marking a proactive financing strategy in the capital markets that further supports the company's long-term growth objectives.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, expected to close on March 23, 2026, demonstrating the company's robust financing capability in the capital markets.
- Debt Repayment Strategy: The net proceeds from this offering will be used to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, aimed at optimizing the company's capital structure and reducing financial costs.
- Underwriter Lineup: Barclays Capital Inc. serves as the global coordinator, while Citigroup, J.P. Morgan, BofA Securities, and HSBC act as active bookrunners, indicating strong market interest and confidence in the offering.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities law, ensuring investors receive necessary investment information, thereby enhancing the company's credibility and transparency in the capital markets.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, which includes $650 million of 4.321% notes, $600 million of 4.398% notes, $750 million of 4.656% notes, $750 million of 4.945% notes, and $750 million of 5.245% notes, all issued at 100% of their principal amount, reflecting strong confidence in the capital markets.
- Use of Proceeds: The net proceeds from this offering will be used alongside cash on hand to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, significantly improving the company's financial structure and reducing debt burden, thereby enhancing future financial flexibility.
- Underwriter Lineup: The offering is being coordinated globally by Barclays Capital Inc., with Citigroup, J.P. Morgan, BofA Securities, and HSBC participating as active bookrunners, indicating strong market recognition and support for the transaction.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities laws, ensuring transparency and compliance, which further boosts investor confidence and lays a solid foundation for the company's future financing activities.
See More
Insider Buying by Waters and Arvinas Directors
- Waters Insider Purchase: Waters' Director Richard H. Fearon bought 1,000 shares at $306.34 each for a total of $306,340, marking his first purchase in the past year, indicating confidence in the company's future.
- Market Opportunity: Waters shares traded as low as $295.02 on Wednesday, 3.7% below Fearon's purchase price, presenting a relatively low entry point for investors, despite the stock being down about 1.2% on the day.
- Arvinas Insider Purchase: Arvinas' Director Briggs Morrison purchased 20,000 shares at $13.40 each for a total investment of $268,070, reflecting his positive outlook on the company's prospects.
- Historical Purchase Comparison: Prior to this purchase, Morrison had bought 227,010 shares at $7.57 each in the past year, demonstrating his sustained confidence in Arvinas, even as the stock fell approximately 3.2% on Wednesday.
See More
Waters CEO to Participate in Healthcare Conference
- Conference Participation: Waters Corporation's CEO, Dr. Udit Batra, will participate in the TD Cowen Healthcare Conference on March 2, 2026, at 11:10 AM ET, highlighting the company's leadership in life sciences.
- Live Webcast: The event will be streamed live on the 'Events & Presentations' section of Waters' Investor Relations website, ensuring global investors can access real-time updates and enhancing corporate transparency.
- Replay Availability: A replay of the webcast will be available for 90 days post-event, allowing investors who missed the live session to catch up, thereby improving information accessibility and engagement.
- Company Background: Waters Corporation focuses on life sciences and diagnostics, dedicated to accelerating scientific innovation through analytical technologies and informatics, driving the release of high-quality medicines and early disease detection, showcasing its global market influence.
See More
